442 related articles for article (PubMed ID: 17977950)
1. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
Højlund K; Glintborg D; Andersen NR; Birk JB; Treebak JT; Frøsig C; Beck-Nielsen H; Wojtaszewski JF
Diabetes; 2008 Feb; 57(2):357-66. PubMed ID: 17977950
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
Glintborg D; Højlund K; Andersen M; Henriksen JE; Beck-Nielsen H; Handberg A
Diabetes Care; 2008 Feb; 31(2):328-34. PubMed ID: 18000176
[TBL] [Abstract][Full Text] [Related]
3. Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
Glintborg D; Højlund K; Andersen NR; Hansen BF; Beck-Nielsen H; Wojtaszewski JF
J Clin Endocrinol Metab; 2008 Sep; 93(9):3618-26. PubMed ID: 18544618
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
[TBL] [Abstract][Full Text] [Related]
6. Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160.
Frøsig C; Rose AJ; Treebak JT; Kiens B; Richter EA; Wojtaszewski JF
Diabetes; 2007 Aug; 56(8):2093-102. PubMed ID: 17513702
[TBL] [Abstract][Full Text] [Related]
7. Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome.
Glintborg D; Frystyk J; Højlund K; Andersen KK; Henriksen JE; Hermann AP; Hagen C; Flyvbjerg A; Andersen M
Clin Endocrinol (Oxf); 2008 Feb; 68(2):165-74. PubMed ID: 17803698
[TBL] [Abstract][Full Text] [Related]
8. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle.
Kramer HF; Witczak CA; Fujii N; Jessen N; Taylor EB; Arnolds DE; Sakamoto K; Hirshman MF; Goodyear LJ
Diabetes; 2006 Jul; 55(7):2067-76. PubMed ID: 16804077
[TBL] [Abstract][Full Text] [Related]
9. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
[TBL] [Abstract][Full Text] [Related]
10. Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.
Glintborg D; Andersen M; Richelsen B; Bruun JM
Clin Endocrinol (Oxf); 2009 Nov; 71(5):652-8. PubMed ID: 19170716
[TBL] [Abstract][Full Text] [Related]
11. The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic.
Thong FS; Bilan PJ; Klip A
Diabetes; 2007 Feb; 56(2):414-23. PubMed ID: 17259386
[TBL] [Abstract][Full Text] [Related]
12. Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.
Johansson J; Feng Y; Shao R; Lönn M; Billig H; Stener-Victorin E
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E551-9. PubMed ID: 20663984
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
15. Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle.
Liu M; Wu K; Mao X; Wu Y; Ouyang J
J Ethnopharmacol; 2010 Jan; 127(1):32-7. PubMed ID: 19800959
[TBL] [Abstract][Full Text] [Related]
16. Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.
Glintborg D; Hermann AP; Andersen M; Hagen C; Beck-Nielsen H; Veldhuis JD; Henriksen JE
Fertil Steril; 2006 Aug; 86(2):385-97. PubMed ID: 16782094
[TBL] [Abstract][Full Text] [Related]
17. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
18. Calmodulin-binding domain of AS160 regulates contraction- but not insulin-stimulated glucose uptake in skeletal muscle.
Kramer HF; Taylor EB; Witczak CA; Fujii N; Hirshman MF; Goodyear LJ
Diabetes; 2007 Dec; 56(12):2854-62. PubMed ID: 17717281
[TBL] [Abstract][Full Text] [Related]
19. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
20. Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation.
Hoy AJ; Bruce CR; Cederberg A; Turner N; James DE; Cooney GJ; Kraegen EW
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1358-64. PubMed ID: 17785505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
